wherein said administration provides for {HEAD ~ selective killing} of {TAIL ~ cancer cells} by direct cytolysis and syncytia formation in cells that are susceptible to replication of the fusogenic mutant HSV 2 
wherein said administration provides for { HEAD ~ selective killing } of { TAIL ~ cancer cells } by direct cytolysis and syncytia formation in cells that are susceptible to replication of the fusogenic mutant HSV 2
OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH